Bard Financial Services Inc. decreased its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 157,557 shares of the pharmacy operator’s stock after selling 5,868 shares during the quarter. CVS Health makes up about 1.2% of Bard Financial Services Inc.’s portfolio, making the stock its 22nd biggest holding. Bard Financial Services Inc.’s holdings in CVS Health were worth $9,907,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory purchased a new stake in CVS Health in the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the third quarter worth about $33,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
Analyst Ratings Changes
Several analysts have recently issued reports on the stock. Piper Sandler reduced their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. Truist Financial reaffirmed a “buy” rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $70.50.
CVS Health Price Performance
CVS Health stock opened at $55.00 on Wednesday. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The business has a fifty day moving average of $59.21 and a two-hundred day moving average of $58.78. The company has a market cap of $69.21 billion, a P/E ratio of 14.00, a price-to-earnings-growth ratio of 0.95 and a beta of 0.54.
CVS Health (NYSE:CVS – Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the company earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts predict that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.
CVS Health Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.84%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Great CPU Race: AMD and Intel Battle for Dominance
- Where to Find Earnings Call Transcripts
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Buy P&G Now, Before It Sets A New All-Time High
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.